Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
SAINT II (Stroke - Acute Ischemic - NXY Treatment)
2004-004803-39Phase 3Completed
- Sponsor
- AstraZeneca
- Start
- Aug 2005
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial of OKN-007 in ischemic stroke (2 arms), sponsored by AstraZeneca. Primary endpoints: Modified Rankin Scale at last rating and National Institute of Health Stroke Scale total score at last rating. Started Aug 2005; status: completed.
02
Drugs
OKN-007
03
Conditions
ischemic stroke
Beyond the preview
Go deeper on 2004-004803-39.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2004-004803-39.